Study shows association between chemotherapy benefit and menopausal status in breast

[News]

After a median follow-up of 5.1 years, among women with lymph node-positive early-stage breast cancer and a recurrence score of 25 or lower who received adjuvant endocrine therapy with or without chemotherapy, postmenopausal patients had no added benefit from chemotherapy, while premenopausal patients who received chemotherapy had improved invasive disease-free survival (IDFS) and an early indication of improved overall survival (OS), according to data from the SWOG S1007 RxPONDER clinical trial presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.

More... (https://www.news-medical.net/news/20201209/Study-shows-association-between-chemotherapy-benefit-and-menopausal-status-in-breast-cancer-patients.aspx)